PASSAGE BIO, INC. Investment Income, Interest
PASSAGE BIO, INC. (PASG) reported Investment Income, Interest of $1.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2022-05-16
- PASSAGE BIO, INC. investment income, interest for the quarter ending 2022-03-31 was $1.00K, a 98.08% decline year-over-year.
- PASSAGE BIO, INC. investment income, interest for the quarter ending 2021-12-31 was $6.00K, a 94.64% decline year-over-year.
- PASSAGE BIO, INC. investment income, interest for the quarter ending 2021-09-30 was $186.00K, a 87.88% increase year-over-year.
- PASSAGE BIO, INC. investment income, interest for the quarter ending 2021-06-30 was $99.00K, a 25.00% decline year-over-year.
- PASSAGE BIO, INC. investment income, interest for fiscal 2021 was $343.00K, a 48.81% decline from fiscal 2020.
- PASSAGE BIO, INC. investment income, interest for fiscal 2020 was $670.00K, a 3.74% decline from fiscal 2019.
- PASSAGE BIO, INC. investment income, interest for fiscal 2019 was $696.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2022-03-31 | $1.00K 10-Q · filed 2022-05-16 | $7.00K derived: sum of 2 quarters · filed 2022-05-16 | $193.00K derived: sum of 3 quarters · filed 2022-05-16 | $292.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $192.00K derived: sum of 2 quarters · filed 2022-03-03 | $291.00K derived: sum of 3 quarters · filed 2022-03-03 | $343.00K 10-K · filed 2022-03-03 |
| 2021-09-30 | $186.00K 10-Q · filed 2021-11-04 | $285.00K derived: sum of 2 quarters · filed 2021-11-04 | $337.00K 10-Q · filed 2021-11-04 | $449.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-06-30 | $99.00K 10-Q · filed 2021-08-05 | $151.00K 10-Q · filed 2021-08-05 | $263.00K derived: sum of 3 quarters · filed 2022-05-16 | $362.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-03-31 | $52.00K 10-Q · filed 2022-05-16 | $164.00K derived: sum of 2 quarters · filed 2022-05-16 | $263.00K derived: sum of 3 quarters · filed 2022-05-16 | $395.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $211.00K derived: sum of 2 quarters · filed 2022-03-03 | $343.00K derived: sum of 3 quarters · filed 2022-03-03 | $670.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | $99.00K 10-Q · filed 2021-11-04 | $231.00K derived: sum of 2 quarters · filed 2021-11-04 | $558.00K 10-Q · filed 2021-11-04 | $999.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $132.00K 10-Q · filed 2021-08-05 | $459.00K 10-Q · filed 2021-08-05 | $900.00K derived: sum of 3 quarters · filed 2021-08-05 | $1.16M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $327.00K 10-Q · filed 2021-05-05 | $768.00K derived: sum of 2 quarters · filed 2021-05-05 | $1.02M derived: sum of 3 quarters · filed 2021-05-05 | |
| 2019-12-31 | $441.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $696.00K derived: sum of 2 quarters · filed 2021-03-03 | $696.00K 10-K · filed 2021-03-03 | |
| 2019-09-30 | $255.00K 10-Q · filed 2020-11-10 | $255.00K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |